FII Hyperion Investments cuts stake by 7.62% via open market sale
AGARWALEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.1 pts more than Nifty Microcap 250 and 0.2 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Singapore-based Hyperion Investments Pte. Ltd., a non-promoter shareholder, sold 24,160,000 equity shares (7.62%) of Dr. Agarwal's Health Care on 12 August 2026 through stock exchanges. Its holding fell from 23.09% (7.32 crore shares) to 15.47% (4.90 crore shares).
Large block sale by a major foreign shareholder may pressure the stock near-term and signals reduced FII ownership concentration.